Showing results (691-700 of 878) with videos related to
Sort By:
Pageof 88
ACS Medicinal Chemistry Letters|April 16, 2020
Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin LigaseKa Yang, Hao Wu, Zhongrui Zhang, et al.Journal of Consulting and Clinical Psychology|March 14, 2017
Depressive symptoms and gestational length among pregnant adolescents: Cluster randomized control trial of CenteringPregnancy® plus group prenatal careJennifer N Felder, Elissa Epel, Jessica B Lewis, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Impact of nutritional status on pathological response and recurrence-free survival in locally advanced oesophagogastric adenocarcinoma treated with perioperative FLOT therapyK Sugiyama, S Kumar, A Chaudry, et al.European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?N R Maisey, M E Hill, A Webb, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot studyM P Findlay, M O Leach, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagusJ S Waters, D Tait, D Cunningham, et al.British Journal of Cancer|August 11, 2005
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecanG Chong, J L B Dickson, D Cunningham, et al.Lancet (London, England)|August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyA L Jones, A S Hill, M Soukop, et al.Clinical Radiology|February 13, 2021
Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shiftS Zafar, R K Sharma, J Cunningham, et al.Hematological Oncology|November 1, 1990
Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisoloneJ B Bell, B C Millar, A Montes-Borinaga, et al.Pageof 88